Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eckhardt

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Thrombosis Research|July 15, 1993
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)A Greinacher, T Eckhardt, J Mussmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Nucleotide sequence of the argR gene of Escherichia coli K-12 and isolation of its product, the arginine repressorD B Lim, J D Oppenheim, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1987
Characterization of the promoter, signal sequence, and amino terminus of a secreted beta-galactosidase from "Streptomyces lividans"T Eckhardt, J Strickler, L Gorniak, et al.
European Journal of Pediatrics|March 1, 1995
Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study GroupK Stehr, U Heininger, R Uhlenbusch, et al.
Nucleic Acids Research|August 11, 1983
Molecular basis for modulated regulation of gene expression in the arginine regulon of Escherichia coli K-12R Cunin, T Eckhardt, J Piette, et al.
The Pediatric Infectious Disease Journal|June 1, 1993
Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in GermanyU Heininger, J D Cherry, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1976
Ornithine delta-transaminase activity in Escherichia coli: its identity with acetylornithine delta-transaminaseJ T Billheimer, H N Carnevale, T Leisinger, et al.
Cancer|October 1, 1982
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)H Breithaupt, H Pralle, T Eckhardt, et al.
The Journal of Clinical Investigation|March 1, 1981
Measurement of desarginine fibrinopeptide B in human bloodT Eckhardt, H L Nossel, A Hurlet-Jensen, et al.
Developments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Thrombosis Research|July 15, 1993
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)A Greinacher, T Eckhardt, J Mussmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Nucleotide sequence of the argR gene of Escherichia coli K-12 and isolation of its product, the arginine repressorD B Lim, J D Oppenheim, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1987
Characterization of the promoter, signal sequence, and amino terminus of a secreted beta-galactosidase from "Streptomyces lividans"T Eckhardt, J Strickler, L Gorniak, et al.
European Journal of Pediatrics|March 1, 1995
Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study GroupK Stehr, U Heininger, R Uhlenbusch, et al.
Nucleic Acids Research|August 11, 1983
Molecular basis for modulated regulation of gene expression in the arginine regulon of Escherichia coli K-12R Cunin, T Eckhardt, J Piette, et al.
The Pediatric Infectious Disease Journal|June 1, 1993
Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in GermanyU Heininger, J D Cherry, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1976
Ornithine delta-transaminase activity in Escherichia coli: its identity with acetylornithine delta-transaminaseJ T Billheimer, H N Carnevale, T Leisinger, et al.
Cancer|October 1, 1982
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)H Breithaupt, H Pralle, T Eckhardt, et al.
The Journal of Clinical Investigation|March 1, 1981
Measurement of desarginine fibrinopeptide B in human bloodT Eckhardt, H L Nossel, A Hurlet-Jensen, et al.
Developments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.
Pageof 4